HOME > TOP STORIES
TOP STORIES
-
BUSINESS Shionogi to Begin PII/III Study for Oral COVID-19 Drug on Sept. 27: President
September 24, 2021
-
BUSINESS Shionogi Gets New Oral COVID-19 Drug into Clinic in Less than 1 Year, Now Gearing Up for PII/III
September 24, 2021
-
ORGANIZATION JPMA Chief Opposes Macroeconomic Indexing, Says Drugs Should Drive Economic Growth
September 22, 2021
-
REGULATORY GSK/Vir’s COVID-19 Drug Up for MHLW Panel Review on Sept. 27
September 22, 2021
-
BUSINESS New Heart Failure Drugs Jostling with Different Modes of Action, Offering Variety of Options
September 21, 2021
-
REGULATORY All 4 Contenders in LDP Leadership Race Vow to Expand COVID-19 Measures
September 21, 2021
-
REGULATORY Japan to Start Discussions in October on Reinstating HPV Vaccine Recommendation
September 21, 2021
-
BUSINESS Sumitomo Dainippon Expects Twymeeg’s Initial Uptake in Combo, but Eyes 1st Line Monotherapy Use Too
September 17, 2021
-
BUSINESS White Matter Found in COVID-19 Vaccine Vials Not Contaminant: Pfizer
September 16, 2021
-
REGULATORY Tainted Moderna Jabs Run Afoul of PMD Law: Minister
September 16, 2021
-
REGULATORY Japan Eyes Legal System to Ensure Generic Supplies in New Industry Vision, Key Official Says It’s Difficult with Companies’ Own Efforts Alone
September 15, 2021
-
REGULATORY Japan Unveils New Pharma Industry Vision, 1st Update in 8 Years
September 14, 2021
-
BUSINESS Chugai Lifts Shipment Curbs for Edirol, Easing Active Vitamin D3 Shortages
September 13, 2021
-
REGULATORY Causal Link between Deaths and Recalled Batch of Moderna Jab “Indeterminable”
September 13, 2021
-
REGULATORY Japan Should Arrange Boosters Immediately, Mix-and-Match Doses Too: LDP
September 10, 2021
-
BUSINESS Follow-On AGs Gaining Ground with 10 Launches in 2 Years, More Expected amid Generic Quality Concerns
September 9, 2021
-
BUSINESS MSD Leading in Oral COVID-19 Drug Race in Japan, Trailed by Pfizer; Shionogi Top Domestic Player
September 8, 2021
-
REGULATORY Japan Strikes Deal for 150 Million Novavax Vaccine Doses, Supply Could Start Early Next Year
September 7, 2021
-
BUSINESS Takeda Faces New Problem on Leuplin, System Glitch Cripples Supply of 1, 3-Month Products
September 7, 2021
-
BUSINESS GSK Files COVID-19 Antibody Drug Sotrovimab in Japan
September 7, 2021
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
